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Abstract 
Cohorts of amyotrophic lateral sclerosis (ALS) patients and control individuals of Caucasian origin from the 
Central European Russia (Moscow city and region) were analysed for the presence of  hexanucleotide repeat 
GGGGCC expansion within the first intron of the C9ORF72 gene. The presence of a large (>40) repeat 
expansion was found in 15% of familial ALS cases (3 out of 20 unrelated familial cases) and 2.5% of 
sporadic ALS cases (6 out of 238) but in none of control cases. These results suggest that the frequency of 
C9ORF72 hexanucleotide repeats expansions in the Central European Russian ALS patients is significantly 
lower than in Western European or Northern American ALS patients of Caucasian origin but higher than in 
Asian ALS patients.  
Key words: amyotrophic lateral sclerosis/mutation/repeat expansion  
1. Introduction 
 Hexanucleotide repeat GGGGCC expansion within the first intron of the C9ORF72 gene located on 
chromosome 9p21 is associated with ALS and FTD (DeJesus-Hernandez et al., 2011; Renton et al., 2011). 
This is the most common genetic defect accounting for approximately 40% of all familial cases of ALS and 
30% of all familial cases of FTD in European and North American populations as well as about 8 % of 
sporadic ALS in the same populations (Majounie et al., 2012). Unaffected individuals commonly have less 
than 25 GGGGCC repeats in each of their C9ORF72 alleles and more than half of them have only two 
repeats (Rutherford et al., 2012). The length of pathogenically expanded repeat loci is highly variable due to 
a wide range, from tens to thousands, of the repeat copy numbers detected in ALS/FTD patients. This might 
explain substantial phenotypic heterogeneity in patients with these expansions although exact correlations 
between the repeat lengths and such clinical characteristics of the disease as the onset, progression rate or 
prevailing symptoms have yet to be firmly established. (Byrne et al., 2012; Cooper-Knock et al., 2012; 
Cooper-Knock et al., 2014; Majounie et al., 2012; Simon-Sanchez et al., 2012) 
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 There is no consensus about the origin of this genetic modification with both a single founder (Mok 
et al., 2012; Smith et al., 2012) and multiple events (Fratta et al., 2014) have been proposed. Geographical 
and population diversity of the repeat expansions in ALS and FTD is substantial. For example, the overall 
average frequency of expansions in Western European FTD patients was approximately 10%, however this 
figure was above 20% for Finland (~29%), Spain (~25%) and Sweden (~21%) but was under 5% for 
Germany (van der Zee et al., 2013). The presence of the repeat expansions is extremely rare in studied Asian 
populations (Jang et al., 2013; Majounie et al., 2012; Ogaki et al., 2012; Soong et al., 2014; Tsai et al., 2012; 
Zou et al., 2013).  
 Considering geographical position of Russian Federation between populations with such substantial 
difference in the frequency of the repeat expansion, information about association of this genetic 
modification with ALS/FTD in various populations throughout this large country can be of particular 
interest. Here we analyzed the C9ORF72 hexanucleotide repeat expansion in ALS patients from the Central 
European Russia region.  
 
2. Material and methods 
2.1. Patients 
 All ALS patients were of Caucasian origin from two specialized Moscow clinics that accept patients 
from the Moscow city and region. These patients did not exhibit symptoms of cognitive impairment. 
Positive family history was registered in 21 patients from 20 unrelated families.  A control group included 
age and sex matched Caucasians from the same region not diagnosed with any chronic diseases at the time 
of blood collection. All participating patients gave their informed consent, and the study was approved by 
the Local Ethics Committee of the Research Center of Neurology. 
2.2. DNA analysis 
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 Genomic DNA was extracted from blood samples using Wizard® Genomic DNA Purification Kit 
(Promega) according to manufacturer instructions. The presence of expanded GGGGCC hexanucleotide 
repeats in C9ORF72 was detected using amplified fragment length polymorphism (AFLP) analysis and 
repeat-primed polymerase chain reaction (PCR). AFLP analysis was performed using fluorescently-labeled 
primers as described previously (DeJesus-Hernandez et al., 2011). Repeat primed PCR (Warner et al., 1996) 
was carried out according to previously published protocol for detection of the C9ORF72 hexanucleotide 
repeats (DeJesus-Hernandez et al., 2011). Characteristic stutter amplification pattern on the 
electrophoregram was considered as an evidence of a pathogenic repeat expansion. Automated ABI Prism 
3130 Genetic Analyzer (ABI) and GeneMapper software (version 4, ABI) for data analysis were used for 
both applications.   Southern hybridization analysis of genomic DNA digested with restriction endonucleases XbaI and 
EcoRI was performed using 32P-labelled pCh9.1 probe as described previously (Buchman et al., 2013).  
3. Results and Discussion 
 The AFLP analysis was carried out for 258 ALS cases and 223 age and sex matching individuals 
from the same geographical region. The samples appearing as “homozygous” in this assay were further 
analyzed using a repeat-primed PCR method to identify the presence of the expansion within one of the 
C9ORF72 alleles.  
 All 223 control subjects had 15 or less hexanucleotide repeats and in the ALS group 249 patients 
also had small number of repeats (≤16) in the C9ORF72 locus with the longest expansion. The repeat size 
distribution was similar in both groups and followed previously observed (Jones et al., 2013) trimodal 
pattern with preferred occurrence of 2, 5 and 8 repeats (Figure 1). The remaining 9 ALS patients (3.5% of 
all studied disease cases) displayed a repeat-primed PCR pattern consistent with the presence of a large 
(>40) repeat expansion in one of their C9ORF72 loci. In this group classified as C9ORF72-ALS the sex 
distribution, site of onset  (see Table A.1), and the average age of onset (54 years) was similar to that in the 
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ALS group without pathological repeat expansion in this locus (average age of onset 52 years). Exon 
sequencing did not reveal mutations in several known ALS associated genes in these patients, however a 
combination with mutations in other genes or certain risk haplotypes as a factors contributing to the 
development of the disease in patients with hexanucleotide repeat expansion cannot be excluded at the 
moment. 
 Three C9ORF72-ALS patients had documented family history (see Table A.2) but only for one of 
these families (Figure A.1) it was possible to obtain DNA samples from the family members. A typical 
pattern of extended repeats was revealed for the proband (DoN-ALS-101), one of whose parents has died 
from ALS, using DNA repeat-primed PCR. This was confirmed by Southern hybridization analysis that 
showed the presence of over 2000 repeats in one C9ORF72 allele (Figure 2). Repeat-primed PCR revealed 
that his only sibling and his only descendant, both healthy at the present time, are carriers of the expanded 
repeats, consistent with reduced penetrance at least up to the age of 42 years (current age of the sibling). Due 
to small size of the family, only 9 of 19 analysed SNPs in the vicinity of the repeat expansion site showed an 
unambiguous link with the presence of the expansion (Table A.3), eight of them were the same as in so-
called Finnish haplotype (Mok et al., 2012). SNP genotyping data for two other patients with family history 
also at least did not contradict this haplotype (data not shown).  Taken together, the hexanucleotide repeat expansion in the C9ORF72 locus is present in 15% of 
familial ALS cases (3 out of 20 unrelated familial cases) and 2.5% of sporadic ALS cases (6 out of 238) in 
the studied population.   In conclusion, we found that the frequency of C9ORF72 hexanucleotide repeats expansions in the 
Central European Russian ALS patients is significantly lower than in Western European or Northern 
American ALS patients of Caucasian origin but still higher than in Asian ALS patients where its rate is 
almost negligible. The impact of this genetic defect to familial ALS was also found to be lower than in other 
studied Caucasian populations.  
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7. Figure legends 
Figure 1. Frequency of distribution of repeat sizes in 249 ALS (open bars) and 223 control (filled bars) 
individuals without pathological (>30) repeat expansions assessed in this study.  
 
Figure 2. Southern blot analysis of GGGGCC repeat expansion in the C9ORF72 locus.  Hybridisation of 
EcoRI and XbaI digested DNA extracted from the whole blood of the patient DoN-ALS-101 and an 
individual without pathological repeat expansion (control) as well as from two cultured lymphoblastoid 
cell lines of patients positive for GGGGCC repeat expansion. 
 
Figure A.1. The family tree for the proband 101 (DoN-ALS-101). Carriers of the repeat expansion in the 
C9ORF72 locus are shown in black squares (males) or circles (females). Numbers designate only those 
family members for whom DNA samples were available for analysis of SNPs shown in Table A.2. 
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Table A.1. Clinical characteristics of ALS patients with C9ORF72 
GGGGCC repeat expansions assessed in this study 
ID Sex Age of onset 
(years) Site of onset Family history of ALS/FTD 
CN-ALS-062 M 42 Lumbar No 
CN-ALS-073 M 53 Bulbar No 
CN-ALS-088 M 63 Lumbar No 
CN-ALS-108 F 30 Bulbar No 
CN-ALS-220 F 65 Lumbar No 
CN-ALS-262 F 65 Thoracic Yes 
CN-ALS-270 M 65 Thoracic Yes 
DoN-ALS-101 M 45 Thoracic Yes 
DoN-ALS-102 M 58 Bulbar No 
 
Table A.2. Evidence of family history of ALS for patients with C9ORF72 
GGGGCC repeat expansions assessed in this study 
Patient ID Relative Age of 
onset 
(years) Age of death (years) Site of onset Symptoms of FTD 
CN-ALS-262 Brother 60 62 Lumbar Not reported 
 Mother 60 65 Lumbar* Not reported 
CN-ALS-270 Father 61 65 Lumbar Not reported 
DoN-ALS-
101 Father Not docu-mented 53 Lumbar* Not reported 
*Formal diagnosis of ALS has not been established but patients suffered from the gait 
abnormalities characteristic for the lumbar form of the disease. 
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Table A.3. Genotypes of SNPs around the C9ORF72 repeat expansion area for 
members of the family shown in Figure A.1. 
SNP 
#101 
(proband) 
#202  
(+ve) 
#205      
(-ve) 
#201 
(+ve) 
linked 
allele 
Consensus 
19 SNP 
"Finnish" 
haplotype 
rs1822723 C/T C/T C/T C/T - C 
rs4879515 C/T C/T C/T C/T - T 
rs868856 C/T C/T C/T C/T - T 
rs7046653 A/G A/G A/G A/G - A 
rs1977661 C/C C/C C/C C/C C C 
rs903603 C/T C/T C/T C/T - C 
rs10812610 C/A C/C A/A C/A C C 
rs2814707 A/G A/G A/G A/G - A 
rs3849942 A/G A/G A/G G/G G A 
rs10122902 G/A G/G G/A G/A G G 
rs10757665 T/C T/C T/C T/C - T 
rs1565948 G/A G/A G/A G/A - G 
rs774359 T/C T/C T/C C/C C C 
rs2282241 G/T G/G G/T G/G G G 
rs1948522 C/C C/C C/C C/C C C 
rs1982915 A/G A/G A/G G/G G G 
rs2453556 A/G A/G A/G A/G - G 
rs702231 C/A C/A C/A C/A - A 
rs696826 A/G G/G A/G A/G G G 
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